IndraLab

Statements


| 2

reach
"Further, a copper chelator inhibited the NLRP3 and not the AIM2, NLRC4, and NLRP1 inflammasomes or NF-kappaB-dependent priming 25."

reach
"A clinically approved copper chelator, tetrathiomolybdate, inhibited the canonical NLRP3 but not the AIM2, NLRC4, and NLRP1 inflammasomes or NF-kappaB-dependent priming."